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,I • 'IRE TREA'IMENT OF LYMPHOSARCOMA
Charles Nice
K. Wilhelm Stenstrom
In discussing the treatment of lympho-
sarcoma, it is necessary to be cognizant
of the general confusion concerninG the
classification of lymph node tumors in
general. The medical literature is re-
plete with various classifications, most
of vThich seem to conte.in various terms
describing pathologic and clinical
manifestations of identical disease
states. To some, the matter of classi-
fication seems fairly exact, and Qe,ll
and Malloryl believe that correct histo-
logic classification of lymphoid tumors
carries a prognostic implication. While
this may' be true to a limited extent,
these authors admit that it is exceed-
ingly difficult to forecast survival
of indiVidual cases.
Regardless of the classification
used, if diagnostic criteria are given
the reader may attempt to relate given
da ta to his preferred classifica tiOD.
At the University of Minnesota Hospitals,
Bell's classification2 is used. Malig-
nant lymph node tumors as a group are
referred to e.s lymphoblastomas. When
possible, a more exact diagnosis is
made on the basis of gross and micro-
scopic pathologic findings, e.nd due
cognizance is given to studies of blood
and sternal marrow aspirate. Bell's
classification is as follo~s:
1. Follicular lymphoblastoma
2. LymphosarcowE
3. Lymphatic leukemia
4. Hodgkin's disease.
Grossly, the lymphoblastomas appear
as tumefactions in lymph nodes or in
almost any tissue. Varying degrees of
fixation to surrounding tissue is often
seen. Usually, a definite diagnosj.s
of the separate types cannot be made
grossly, although at times macroscopic
areas of fibrosis or necrosis are
preeent. Microscopically, the lsmpho-
blastomas as a group are characterized
by overgrowth of elements normally pres-
ent, with resultant distortion of the
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architecture of the tissue and invasion
of nodal c82sule or surrounding tissue.
Follicular lymphoblastoma (Brill-
SJ~errs disease) is characterized by
numerical and dimensional hyperplasia
of lymphoid follicles in such manner
that general architecture of the normal
IJ~phoid follicle is ~bintained or
simulated. This microscopic picture is
regarded as a relatively less malignant
phase of lymphoid neoplasia "Thich is
followed by a more malignant picture
which may be l~nphosarcoma, lymphatic
leukemia or Hodgkin's disease.
L;vmphosarcoma is characterized by
the presence of unmature cells of the
lymI1hocyte series. There may be rela-
tively large or small cells, and mitotic
figures are seell in variable numbers.
The tumor often designated as reticulum
cell sarcoma is included under lympho-
sarcoma. Also, an occasionul histologic
picture of lymphosarcoma may be accom-
panied or followed by a blood picture of
lymphatie leukemia. The latter are not
included in this series as true cases of
lymphosarcoma.
Hodgkin I s disease is characterized by
large mononuclear or multinuclear Reed-
Sternberg cells, with variable amounts
of necros is arid/or fibros is, and often
an incroased number of eosinoI,hiles.
If the larGe mononuclear cells form the
major pare of the histologic structure a
diagnosis of HodgkirJ's sarcoma may be
made, but this is at times difficult to
differentiate from lymphosarcoma with
large cells (reticulum cell carcinoma).
Further differentiation into Hodgkin's
granuloma and paragranuloma is not con-
sidered necessary.
In lympha tic leukemia the histologic
picture of tissue biopsy sections is
that of a homogeneous mass of cells re-
sembling the mature lymphocyte and mito-
tic figures are infrequent. If the blood
picture is norme.l a diagnosis of aleuke-
mic leukemia is marle.
If the morIihologic IJicture is that of
neoplastic l.ymphoid tissue but strict
classification seems impossible, the
diaC"..'1osis is BiverJ simply as malignant
lymphoblasto1J1..a. It should be empha-
sized here that the histologic structure
often varies when serial biopsies and
pOS~lortem studies are compared. It is
likewise not uncommon to see two or
more of the above described histologic
patterns from various sites of a single
body at postmortem. A case report is
being prepared by a member of staff of
the Veterans Hospital, Minneapolis, in
which four distinct histologic patterns
were seen on three serial biopsies and
postmortem covering a four-year period.
Material Presented
The study presented here includes
all of the patients referred with a his-
tologic diagnosis of J.ymphosarcoma to
the Department of Irradiation Therapy
from January, 1930 to December, 1943.
In the tables, only those cases are in-
cluded for which microscopic slides
could be obtained for checking the diag-
nosis. The slides were reviewed by
Dr. Robert Hebbel of the Department of
Pathology. The five-year survival fig-
ures include 36 cases treated up to
December, 1944, and a total of 63 cases
treated up to D~cember, 1948, are in-
cluded in the survival table. A smaller
group of 22 cases, for whom slides
could not be obtained for checking were
studied separately and did not appear
to show significant differences. Those
cases which underwent surgery are con-
sidered later in the discussion. Only
one of the patients received nitrogen
mustards (at Ancker Hospital, st. Paul),
and no unusual change in the course of
that patient was noted.
Method of Irradiation
local irradiation is used first in
almost all cases with total body or
spray irradiation being reserved for
patients with widely disseminated dis-
ease or those who do not respond favor-
ably to local irradiation.
In treating lymphosarcoma, as in all
lymphoblastomas except lymphatic leu-
kemia (With leukemic blood picture) in-
tensive local roentgen irradiation j.s
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given with the object of attaining a
tumor dose of about 2000 tissue roent-
gens in fourteen days. In areas such
as in the cervical region, this is
achieved by giving about 900 roentgen
in air to each of three fields: anterior,
posterior, and lateral. Factors in-
elude: 220 KIf, 15 ma., 60-70 em. dis-
tance, with filter of 0.5 to 1.0 rom. cu,
wi th half-value-layers of 1.35 and 1.8
rom. cu respectively. In treating large
mediastinal nodes, treatment is started
with small doses of 50-100 roentgen in
air, in order to avoid pulmonary com-
plications due to bronchial compression
by soft tissue edema.
In Table 1, the survival data on the
63 cases of lymphosarcoma are given.
The histologic sections have been veri-
fied, as stated above, by Dr. Hebbel for
this study. Since our follow-up data
is complete only up to 1949, we may
consider only the 36 eases seen up to
December, 1944, in our actual five-year
survival figure of 19%.
For the sake of comparison, average
survival and five year survival data of
the cases of lymphosarcoma and other
lymphoblastomas are tabula ted in Table 2.
The designation "not rechecked" under
lymphosarcoma and lymphoblastoma indicates
that a histologic di~gnosis has been made
by a member of our pathology staff, but
that the slides were not available for
confirmation for the present study. It
is easily seen that, with the possible
exception of the lymphatic leukemia
group, the size of each group is so
small that no real statistical difference
is noted. The cases designated "clini-
ca1 lymphob las toma" inc lude those pa-
tients in which tissue biopsy seemed
impractical at the time, but in which
clinical findings favored a diagnosis of
malignant lymphoid tumor. For example,
if mediastinal l;ymphadenopa thy were
noted on the chest roentgenogram, and
other likely causes were ruled out by
appropriate studies, the patient might
then be subjected to a "therapeutic test"
with irradiation. If appropriate re-
sponse then occurred and the subsequent
clinical course seemed to further sub-
Table 1
SURVIVAL FArm IN LYMPHOSARCOMA AFTER FIRST TREAr:rMENT
(63 Positive Biopsy Cases)
No.of Survival
year Cases in Months Survival in Years
1 3 6 9 1 2 3 4 5 6 7 8 9 10
1930 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1931 0
1932 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0
1933 2 1 1 1 1 1 0 0 0 0 0 0 0 0 0
1934 2 2 1 0 0 0 0 0 0 0 0 0 0 0 0
1935 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0
1936 0
1937 0
1938 3 3 3 1 1 1 1 1 1 0 0 0 Q 0 0
1939 3 3 3 2 2 2 2 2 " 2 2 2 2 2 1c:
1940 4 4 3 3 3 3 2 2 2 1 0 0 0 0
1941 4 4 3 1 1 1 0 0 0 0 0 0 0
1942 4 4 3 3 2 2 0 0 0 0 0 0
1943 7 7 c: 5 4 4 3 3 3 3 2./
1944 4 4 2 1 1 1 0 0 0 0
1945 8 8 7 6 5 4 3 2 2
1946 6 6 6 5 5 5 4 1
1947 7 7 6 4 4 4 2
1948 6 6 6 4 2 2
cases 63 63 63 63 63 63 57 50 44 36 32 25 21 17 13
Survival 61 49 36 32 32 18 13 11 7 5 2 2 2 1
Per cent 97 78 57 51 I 51 32 26 25 19 16 8 10 12 8
Table 2
AVEFAGE AND FIVE-YEAR SURVIVAL DATA ON 254 CASES OF
LYMPHOBIASTOMA EXCLUDING HODGKIN I S DISEASE
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Months No. of Per Cent
No. of Averae-;e 5-Year 5-Year
Cases Survival Survival Survival
LYmphatic Leukemia 122 17.2 12 10
Aleukemia Leukemia
Rechecked 6 22,3 1 17
Not rechecked 5 96.0 3 60
:4Ymphosnrcoma
Rechecked 36 26.0 7 19
Not rechecked 22 30.0 6 27
4'mPhoblastoma
Rechecked 8 22.6 1 13
Not rechecked 27 26.0 5 19
Clinical Lymphoblastoma 20 23.0 2 10
Follicular Lymphoblastoma 8 27.0 1 13
-- -
Totals 254 22.9 37 14.7
..,.
stantiate th~ findings, the case was
considered to belong to the malignant
lymphoid tumor group. In this manner,
we have attempted to avoid exclusion of
any possible lymphoid tumor from our
observations.
It is to be noted that only one of
eight cases of follicular lymphoblastoma
survived five years (13%) and the aver-
age survival of this admittedly small
group is only 27 months. Where further
studies were possible in this group,
for example, la ter biopsy, blood or
autopsy material, a transition to
lymphatic leukemia, lymphosarcoma or
Hodglcin I s disease occurred. In other
words, as far as we know, the patients
did not actually die of follicular
l;ymphoblastoma, but should actually be
considered as dying of one of the other
malignant conditions.
An attempt was made to correlate
survival in lymphosarcoma with other
factors. For example, the rola tionship
of survival after the first roentgen
treatment was compared with age of the
patients. Although no striking corre-
lation was noted, there is a tendency
for older patients to live longer.
This has also been noted in lymphatic
leukemia, and these deviate from the
apparent longer average survival in the
second, fourth and fifth decades noted
in Hodgkin's disease. 3 Survival from
onset to death was also compared with
age groups and essentially the same
findings were obtained. Survival
after the first roentgen treatment yms
also compared with the time elapsing
from onset to first treatment; it seems
that there is a tendency toward longer
totBl survival in patients treated early,
although this is not constant.
In the group of patients who lived
three or more years from time of onset,
it was noted that most of the cases of
lymDhosarcoma were treated relatively
early, for example, within the first
six months. However, many of the pa-
tients with short total survival were
also treated relatively early, so that
although early treatment is deemed de-
sirable it is not the only factor con-
cerned in those cases with ultimately
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long total survival.
Results of Others
Hamann4 reported a five-year survival
of 12% in 77 cases of lymphosarcoma.
Hare et a15 reported a five-year sur-
vival of 28.7% in 181 cases of lymphoid
tumors excludinG lympha tic leukemia.
Craver6 reported 26.3% five-year sur-
vival in 308 cases of lymphosarcoma.
stout7 reported 170 cases of lJ~pho­
sarcoma. Of these, 51 had received no
treatment and only one survived 5 years
(2%). Of 119 patients, treated by
radiotherapy, surgery, or a combination
of the two, 28 lived 5 years (23~5%),
and 16 lived 10 years (13.4%). Of
these latter 16 patients, all but one
were free of symptoms at last report.
Localized lymphosarcoma of the head
and neck offgrs a fairly good progno-
sis. Craver quotes Catlin's study of
50 such cases treated by surgery and
irradiation with a five-year survival
of 52%.
Localized
As early as 1893, Kundra t 9 recogn ized
that at least some cases of lymphosar-
coma start as localized disease process-
es and he advocated surgical treatment
in these cases.
GalllO reported 48 cases of malig-
nant lymphoma (lymphoblastoma) of all
types that appeared to be localized and
which were treated with surgical pro-
cedures. Of these, 23 lived five years
and 8 lived 10 years. Gall stated that
surgery is preferable to irradiation
in these cases, but it is to be noted
that in 16 of the 23 patients surviving
five years irradiation therapy was given
following operation or at time of recur-
rence. Also, in 7 of 8 patients sur-
viving ten years, irradiation therapy
was given. Some of these were given
irradiation as early as 0.2 year after
surgery for recurrence, while others
went as long as seven years before re-
currence. In any case, it is difficult
to separate the possible advantages
offered by both surgery and irradiation
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Table 3
Involvement of two or more
proximal lymph node regions
confined to either upper or
lower trunk, with or without
constitutional symptoms.
Involvement of only one
lymph node region or a sin-
gle lesion elsewhere, with
no constitutional symptoms.
Involvement of multiple
lymph node regions with or
without constitutional symp-
tams or acute disease with
no obvious lymphatic in-
volvement. (To this 8roup
there may be added also
those patients with exten-
sive mediastinal or pleural
involvement, peritoneal im-
plants, or palpable liver
or abdominal nodes).
I.
II.
Clinical Staging of Lympho-
blastomas (modified after
peters)
stage
Stage
Stage III.
In Table 3 we have given a slightly
modified version of Peter's clinical
staging which we have attempted to apply
to our patients. Of the 36 patients
available for five-year survival study,
eight were in StaBe I and all oeven of
the five-year survivals were in this
group. Six of these patients were alive
when seen last. None of the remaining
28 patients in Stages II and III sur-
vived five years} although there is a
I, tendency for longer survival in Stage II
as compared to Stage III. In an attempt
to study our data further, we have
staged our 63 proved cases of lymphosar-
coma and have further sub-divided the
cases into those treated by irradiation
only, those treated by surgery followed
almost immediately by irradiation, and
those trea ted b;y' surgery followed by
irradiation at time of recurrence. This
data is tabula'~ed in Table 4. Although
the individual Broups are small, certain
trends may be noted. In Stage I the
prognosis seems to be better whether the
cases are treated by irradiation alone
In the experimental field, Furth
and Kahn12 introduced a sing19 cell
into susceptible mice and in several
instances obtained ultimate development
of uniformly Widespread leukemic lesions.
Leukemic and sarcomatous lymphocytes
exhibit varying degrees of infiltrative
and metastatic capability in mice.
Those which produce large tumors when
inoculated subcutaneously invade the
blood stream less readily than those
which produce very s~Bll flat tumors. 13
Clinical Staginf;,
of 4'mPh Node Tumors
Peters14 has extended the idea of
relative localization and dissemination
in reporting over-all survival statis-
tics in Hod8kin' s disease. She listed
clinical Stages I, II, and III and ob-
tained the very good figures of 88%
five-year survival in 35 cases of Stage
72% in 32 cases of Stage II and 9% in
46 cases of Stage III, with a 51% fig-
ure for the total of 113 cases proved
by biopsy. She found that clinical
staging was more important as a prog-
nostic aid than sub-dividing Hodgkin's
disease into paragranuloma, granul~1a
and sarcoma. This same idea is noted
in the reports of Gall and Hellwig
cited above, in cases of other lymphoid
tumors, namely, that an apparently
localized lymphoblastoma has a better
prognosis than a disseminated tumor, re-
gardless of histologic structure.
in this group. Gall also observed that
only 4 of 33 patients with malignant
l;ymphoid tumor of the gastro··intestinal
tract had l~~ph node metastase8; 16 bad
enlarged nodes, which on histologi~
examination revealed inflammation or
hyperplasia.
Hellwigll reported localized disease
in 10% of 135 autopsies of patients
with lymphoblastomas, and cited good
results with surgery or a combination
of surgery and irradiation in these
cases. 1welve of 25 patients treated
by surgery alone were still free of
disease five years later. Of 42 patients
receiving both surgery and irradiation,
18 lived five years, and nine were still
free of disease.
>,
1
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or by surgery followed by irradiation an occasional local tumor is not cam-
in a few days. We }irefer sur5ical pletely eradicated by relatively intense
excision followed by irradiation because local irradiation. fJ,s a corollary evi-
Table 4
LYM.tDflOSARCOMA - - JR.ttADIATION THERAPY
STAGE CASE NO. ONSET TO X-RX. ONSET TO DEATH X-RX TO DEATH
I 1 0.25 yr. 7.8.a. yr. 7.6+ yr.
2 0.1 6.6+ 6.5'"
3 0.4 4.1+ 3·7+
4 0.25 6.4+ 6.2+
5 0·3 4.7+ 4.4 ...
6 0.6 5.2 4.6
AV. 6.0 5.'6
II 7 1.0 5.0 4.0
8 0.2 3·3 .. 3·1...
9 0·5 1.6 1.1
10 0.2 1.9 1.7
AV. 3.0 2T
III 11 1.0 1. 74 0·7+
12 0·7 3·5 2.8
13 0.2 0.5 0·3
14 0.25 3.2 ... 2.95 ...
15 0.3 1.75 1.45
16 0.25 0.4+ 0.15'"
17 0.2 1.5 1.3
18 0.1 1.3 1.2
19 0·3 2.1 1.8
20 0.2 0.3 0.1
21 0.2 0.3 0.1
22 0.2 0.3 0.1
23 0·3 0.32 0.025
24 0.4 0.6 0.2
25 0.25 0.5 0.25
26 0-3 1.3 1.0
27 0.5 0.6 0.1
28 0.5 0.7 0.2
29 0.2 0.25 0.05
30 0.5 0.75 0.25
31 0.5 0.6 0.1
32 0.4 2.25 1.85
33 0.25 0.4 0.15
34 0.025 0.2 0.2
35 0.25 0.5 0.25
36 0.2 0.25 0.05
37 1.25 2.0 0.75
38 0.8 1.2 0.4
AV. 1.04 0.7
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Table 4 (Cont.)
LYMPHOSARCOM(.l.--SUIDERY PLUS IRRADIATION
CASE ONSET TO SUffiERY ONSET TO SUffiERY X-RX TO
STAGE NO. SUffiERY TO X-RX. DEATH TO DEATH DEATH
I 39 1.25 yr. 0.1 11.1", 9·9'" 9.8 ...
40 0.2 0.15 2.6 t 2.4", 2.25'"
41 3.75 1.6 7.9 4.2 5.75
42 0.1 0·7 4.1... 4.0.. 3·3+
43 0.1 0.008 1.6... 1.5· 1.5'"
44 0.9 0.75 11.3+ 10.6+ 11.3'"
0.05
45 0.4 0.05 7.2 ... 6.75 6.75
46 0.9 0.05 4.8 ... 3.8 3.8
AV. 6.3 5.15 5.6
II 47 0.1 0.05 4.7 4.6 4.6
48 0.25 0.1 2.1, 1.8 1.75
49 0.25 0.02 2.7'" 2.4+ 2.4",
50 0.05 3.0", 3.0., 3.0+
AV. 3·1 3.0 3.0
III 51 0.5 -0.25 2.0 1.5 1.75
52 0.9 0.05 4.75+ 3.8+ 3·9+
53 0.1 0.1 2.0 1.9 1.8
54 0.25 0.25 0.5 0.3 0.5
1 55 0.25 0.1 0.3 0.1 0.0f 56 ? 0.2 ? 0.3 0.2I
57 0.3 0.05 0.6 0.3 0.25
58 0.1 0.05 1.6 1.5 1.5
59 0.2 0.05 0.3 0.2 0.2I AV. 1.5 1.1 1.12
I
~ SYMPHOSARCOMA - -S'(JR}ERY PLUS IRRADIATIONi
FOR RECURRENCE
CASE ONSET TO SUffiERY ONSET Iro SUEGERY X-RX TO
STAGE NO. SUffiERY TO X-RX. DEATH TO DEATH DEATH
I 60 0.8 yr. 0.25 1.4 0.5 0.25
61 ? 11.75 12 .O? 12 .0 0.25
62 ? 0.4 0.75 0.75· 0.3'"
63 0.3 0.9 1.5 1.2 0.25,
3.6 0.25r AV. 3.9
dence it has been noted in treating may be developing along with recurrence
localized lymphosarcoma in mice, re- of the local tumor.
sponse to irradiation is not as complete
~
after the tumor has reached a fairly It should also be emphasized that
lare;e size 15 . Further, we do not con- there is a difference in the natural
sider it wise to wait until recurrence history of lymphoid tumors as seen in
., follows local incision for where even various patients. Thus we see that a
a few tumor ce lls are left, metastases patient may appear for treatment at
three months after onset and may
either present ~ocalized or disseminated
disease. This is probably a very great
factor in the longer survival noted in
localized cases. However, considering
Stout's series of untreated cases cited
above, and from our own observation
that we rarely see a patient present
himself a year after onset wHh disease
still localized, it seems probable that
in the vast majority of patients dis-
semination will occur if proper therapy
is not instituted as soon as possible.
Therefore, we believe that an intensive
therapeutic approach is warranted when
the lesion seems to be localized, and
that such an approach often greatly
increases survival.
~ Therapeutic Agents
Various chemical agents have been
used in treating lymphoblastomas.
Fowler's solution has been used in
cases of lymphatic leukemia where there
is a tendency toward the acute phase of
disease, and occasionally for main-
tenance therapy. In the past few years
nitrogen mustards, radiophosphorus,
nitrogen mustards and folic acid antag-
onists have been used in leukemia and
allied disorders, of lymphoid tissue.
These agents have at times proved useful
as palliative agents and as adjuncts
to irradiation therapy, but as Craver16
so aptly states, these agents cannot
supplant radical surgery followed by in-
tensive irradiation in those cases with
relatively localized disease.
Kirschbaum et al17 delayed or pre-
vented developnent of lymphatic leukemia
in mice with various chemical agents
when injections were started within a few
days after transfer, but none showed
prolonged survival when injections were
delayed until eight days after transfer.
No chemical agent yet known causes a pal-
pable twnor to disappear, such as is seen
after irradiation. As a rule, these
local tumors recur and metastasize in
mice treated by irradiation, with little
or no increase in total survival. This
is in contrast to the effect of irradia-
tion in the human, where recurrence of
the local tumor may be prevented and
total survival apparently lengthened.
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Summary
It is necessary to consider lymph
node tumors as a group and to understand
the relationship of the various types
to each other in considering classifi-
cation and therapy of these tumors.
Clinical staging of the extent of dis-
ease, which in turn is greatly indepen-
dent on the natural history of the in-
diVidual tumor in a given patient, is
apparently the most important prognostic
factor in lymphosarcoma as well as in
other lymph node tumors.
LYmphosarcoma in localized form is
probably best treated by surgical ex-
cision followed by intensive local ir-
radiation.
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r II. MEDICAL SCHOOL NEWS
Coming Events
April 16-18 Diseases of the Blood in
Infancy and Childhood
April 16-21 Cont1nuationCourse 1L Proc-
tology for General Physicians
April 26-28 Continuation Course in
Atomic Medicine for General Physicians
May 7-11 Continuatmn Course in Electro-
cardiography for General Physicians
May 8 George E. Fahr Locture; "Certain
Mechanical Peculiarities of the Heart ll ,
George E. Burch, Tulane University
School of Medicine
* * *
Atomic Medicine Course
A continuation course in Atomic Medi-
cine will be presented for physicians of
Minnesota April 26, 27, and 28 in the
Museum of Natural History Auditorium.
Emphasis will be placed on the role of
the physician in civilian defense against
atomic weapons. lIElements of Nuclear
Physics lf and "The Phenomenology of the
Atomic Bomb" will be opening presenta-
tions. Following this consideration will
be given to the pathology and clinical
effects of radiation. Psychological
effects of catastrophe and methods of
providing blood and blood substitutes on
a large scale will also be presented.
The course will close with a round table
discussion of the problems to be met and
the methods to be utilized in the event
of atomic bombing of the Minneapolis-
st. Paul area. Dr. George M. Lyon, Chief
of the Rad:~oisotope Section of the Vet-
erans Administration, Washington, D.C.,
will be the guest faculty member for the
course. He will discuss "The Organiza-
tion of Radef." All Minnesota physicians
are invited to attend the course which is
presented without tuition charge. Ad-
vance registration is requested.
* * *
lIHypertension - A Symposiumlf , edited
by Dr. E. T. Bell has rocently been pub-
lished by the University of Minnesota
Pross. The book contains the proceedings
of the Symposium held at the University
of Minnesota September 18, 19, and 20
in honor of Doctors Elexious T. Bell,
Benjamin J. Clawson, and George E. Fahr.
The papers, many of which were presented
in an abbreviated form during the Sym-
posium, are presented in the recorded
volume in their e~tirety together with
a complete transcription of all discus-
sion. It can certainly be said that the
book contains the present-day concepts
of the world's foremost authorities in
this important field of medicine. In
addition to formal papers which were pre-
sented by Doctors Bell, Clawson, and
Fahr, a brief biographical sketch of
each of those three distinguished facul-
ty members is presented. V'any medical
alumni and friends will wish to obtain
copies not only for their scientific
value, but also as a remembrance of the
occasion.
* * *
Faculty News
Dr. Wesley W. Spink attended the
annual meeting of the American College
of Physicians April 9-13 in st. Louis,
Missouri. Dr. Spink represents ~1inne­
sota on the Board of Governors of the
organization.
Doctors Owen H. Wangensteen, Richard
L. Varco, and Clarence Dennis will attend
the meeting of the American Surgical
Association in Washington, D.C. April 11,
12, and 13. Dr. Wangensteen will present
a paper on "A Physiological Operation for
Mega-esophagus." Dr. Dennis will present
results of his studies on "The Develop-
ment of a Pump-Oxygenator Apparatus to
Supplant the Human Heart and Lungs for
Periods Adequate to Permit Repair of
Intracardiac Congenital Lesions." Dr.
Wangensteen will also attend a meoting of
the Board of Regents of the American
College of Surgeons April 13-15 in Wash-
ington, and the annual meeting of the
American Association for Thoracic Surgery
April 16-18 in Atlant:l.c Cit;y.
Dr. Donald W. Cowan has recently been
electod Vice-President of the North
Central Section of the American College
Health Association which met in Ames,
Iowa, April 6 and 7.
III. UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
WEEKLY CALENDAR OF EVENTS
Visitors Welcome
April 16 - 21, 1951
Monday, April 16
430 .
Medical ?chool and University Hospitals
9:00 - 9:50 Roentgenology-Medicine Conference; L. G. Rigler, C. J. Watson and
Staff; Todd Amphitheater) U. H.
9:00 - 10:50 Obstetrics and Gynecology Conference; J. L. McKelvey and Staff;
l-1-l09, u. H.
10:00 - 12:00 Neurology Rounds; A. B. Baker and Staff; Station 50, U. H.
11:00 - 11:50 Physical Medicine Seminar; Effects of Massage on Circulation;
Margaret P. Ladd; E-lOl, U. H.
11:00 - 12:00 Cancer Clinic; K. Stenstrom and A. Kremen; Eustis Amphitheater, U. H.
12:00 - 12:50 Physiology Seminar; Pulmonary Edema in Hypoxia and OXygen Poisoning;
Allan Hemingway; 214 Millard Hall.
12:15 - 1:20 Obstetr~cs and Gynecology Journal Club; Staff Dining Room, U. H.
1:30 - 2:30 Pediatric-Neurological Rounds; R. Jensen, A. B. Baker and Staff; U. H.
4:00 - Public Health Seminar; 113 Modical Sciences.
4:00 - Pediatric Seminar; Streptococcal Enzymes; Benjamin Katz; Sixth Floor
West, U. H.
4:30 - 5:30 DermatoloGical Seminar; M-436, U. H.
5:00 - 5:50 Clinical Medical Pathologic Conference; Todd Amphitheater, U. H.
5:00 - 6:00 Urology-Roentgenology Conference; C. D. Creevy, O. J. Baggenstoss,
and Staffs; Powell Hall Amphitheater.
Minneapolis General Hospital
8:30 - 10:00 Pediatric Rounds; Dr. Lowry; 7th Floor Annex.
11:00 - Pediatric Rounds; Franklin Top; 7th Floor Annex.
1:00 - 2:00 Staff Meeting; Classroom, 4th Floor.
1:30 - Pediatr~.c Rounds; Dr. Ulstrom; 5th Floor Annex.
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Monday, April 16 (Cont.)
Veterans Administration Hospital
9:00 -
11:30 -
1:00 -
4:00 -
G. I. Roundsj R. V. Ebert, J. A. Wilson, Norman Shrifterj Bldg. I.
X-ray Conferences; Conference Room; Bldg. I.
Metabolic Disease Rounds; N. E. Jacobson and G. V. Loomis; Bldg. I~
Med:ical Surgical Conference; Conference Room, Bldg. 1.
Tuesday, April 17
Medical School and University Hos~ita!~
9:00 - 9:50 Roentgenology-Pediatric Conferenco; L. G. Riglor, I. McQuarrie and
Staffs; Eustis Amphitheater, U. H.
9:00 - 12:00 Cardiovascular Rounds; Station 30, U. H.
12:30 - 1:20 Pathology Conference; Autopsies; J. R. Dawson and Staff; 102 I. A.
1:00 - 2:00 Phys~ology Seminar on Cardiac Metabolism; 129 Millard Hall.
3:15 - 4:20 Gynecology Chart Conference; J. L. McKelvey and Staff; Station 54,
U. H.
4:00 5:00 Pediatric Rounds on Wards; I. McQuarrie and Staff; U. H.
4:00 - 5:00 Electrocardiographic Conference; EKG Laboratory, 6th Floor, U. H.
5:00 - 6:00 X-ray Conference; Presentation of Cases by University Hospitals
Staff; Eustis Amphitheater, U. H.
8: 00 p.m. Minnesota Pathological Society Meetingj The Relation of Carcinoma of
the Stomach to Chronic Gastritisj Robert Hebbelj Medical Science
Amphitheator.
Ancker Hospital
8:00 - 9:00 Fracture Conferencej Auditorium.
1:00 - 2:30 X-ray Surgery Conferencoj Auditorium.
Veterans Administration Hospital
8:45
9:30 -
10:30 -
1:00 -
1:30 -
Surgery Journal Clubj Conference Room, Bldg. I;
Surgery-Pathology Conference; Conference Room, Bldg. I.
Surgery Tumor Conferencej Conferenco Room, Bldg. I.
Chest Surgery Conference; T. Kinsella and Wm. Tuckerj Conference
Room, Bldg. 1.
Liver Rounds; Samuel Nesbitt.
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Tuesday, April 17 (Cant.)
Veterans Adm:i.nistraUon Hospita! (Cant.)
2:00 - 2:50 Derm~tology and Syphilology Conference; H. E. Michelson and Staff;
~ Bldg. III.
3:30 - 4:20 Autopsy Conference; E. T. Bell and Donald Gleason; Conference Room,
Bldg. Ie
Wednesday, April 18
Medical School and University Hospitals
8:00 - 8:50 Surgery Journal Club; O. H. Wangensteen and Staff; M-l09, U. H.
8:00 - 9:00 Roentgenology-Surgical-Pathological Conference; Allen Judd and
L. G. Rigler; Todd Amphitheater, U. H.
11:00 - 12:00 Pathology-Medicine-Surgery Conference; Surgery Case; O. H. Wangen-
steen, C. J. Watson and Staffs; Todd Amphitheater, U. H.
12:00 - 1:00 Radioisotope Seminar; Liver Regeneration in PGA (Folic Acid) Defi-
cient Rats; C. U. Lowe and C. P. Barnum; 113 MOdical Sciences.
5:00 - 5:50 Urology-Pathological Conference; C. D. Creevy and Staff; Eustis
Amphi theater.
5:00 - 7:00 Dermatology Clinical Seminar; Dining Room, U. H.
7:00 - 8:00 Dermatology Journal Club; Dining Room, U. H.
8:00 - 10:00 Dermatological-Pathology Conference; Review of Histopathology
Section; Robert Goltz; Todd Amphitheater, U. H.
Ancker Hospital
8:30 - 9:30 Clinico-Pathological Conference; Auditorium.
3:30 - 4:30 Journal Club; Surgery Office.
Minneapolis General Hospital
8:30 -
9:00 -
Pediatric Rounds; Dr. Lowry; 7th Floor Annex.
Pediatric Allergy Rounds; Dr. Nelson; 4th Floor Annex.
11:00 - 12:00 Pediatric Rounds; Franklin Top; 7th Floor Annex.
12:15 -
1:30 -
Staff Moeting; 4th Floor Annex.
Pediatric Rounds; Dr. Huenekens and Dr. Ulstrom; 5th Floor Annex.
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Wednesday, April 18 (Cont.)
Veterans Administration Hospital
8:30 - 10:00 Orthopedic-Roentgenologic Conference; Edward T. Evans and Bern~rd
otLoughlin; Conference Room, Bldg. I.
8:30 - 12:00 Neurology Rehabilitation and Case Conference; A. B. Baker
2:00 - 4:00 Infectious Disease ROIDlds; Main Conference Room, Bldg. I.
4:00 - 5:00 Infectious Disease Conference; W. Spink; Conference Room, Bldg. I.
7:00 p.m. Lectures in Basic Science of Orthopedics; Conference Room, Bldg. I.
Thursday, April 19
Medical School and University Hospitals
9:00 - 9:50 Medicine Case Presentation; C. J. Watson and Staff; M-I09, U. H.
10:00 - 11:50 Medicine Ward Rounds; C. J. Watson and Staff; E-221, U. H.
Cancer Clinic; K. Stenstrom and A. Kremen; Todd Amphitheater, U. H.
Medical Film; The Therapeutic Use of ACTH in Human Disease; Todd
Amphitheater, U. H.
Ophthalmology Ward Rounds; Erling W. Hansen and Staff; E-534, U. H.
Modical Film; The Thorapeutic Use of ACTH in Human Disease; Todd
Amphitheater, U. H.
Physiological Chemistry Seminar; H. M. Cavert; 214 Millard Hall.
Radiology Seminar; Benign Esophageal Constrictions Simulating
Carcinoma; Joseph Asta; Eustis Amphitheater, U. H.
Podiatrics Cardiology Conference and Journal Club; Review of Current
Literature 1st hour and Review of Patients 2nd hour; 206 Temporary
West Hospital.
11:00 - 12:00
12:00 -
1:00 -
4:30 - 5:20
4:30 -
5:00 - 6:00
7:30 - 9:30
Minneapolis General Hospital
8:30 - Neurology Rounds; Dr. Heilig; 4th Floor Annex.
11:30 - Pathology Conference; Main Classroom.
1:00 - 2:00 EKG and X-ray Conference; Classroom, 4th Floor Annex.
2:00 - Psychiatry Rounds; Dr. Benton; 4th Floor Annex.
Veterans Administration Hospital
8:00 - Surgery Ward Rounds; Lyle Hay and Staff.
9:15 - Sl~gery Grand Rounds; Conference Room, Bldg. I.
Thursday, April 19 (Cont.)
Veterans Administration Hospital (Cont.)
11:00 -
2:15 -
Surgery-Roentgen Conference; Conference Room, Bldg. I.
Chest Rounds; William Stead.
Friday, April 20
Medical School and University Hospitals
8:30 - 10:00 Neurology Grand Rounds; A. B. Baker and Staff; Station 50, U. H.
9:00 - 9:50 Medicine Grand Rounds; C. J. Watson and Staff; Todd Amphitheater, U.H.
10:00 - 11:50 Medicine Ward Rounds; C. J. Watson and Staff; E-22l, U. H.
10:30 - 11:50 Otolaryngology Case StUdies; L. R. Boies and Staff; Out-Patient
Department, U. H.
11:45 - 12:50 University of Minnesota Hospitals Staff Meeting; The Use of Staples
in Ortho-Surgery; Edward H. Kelly; Powell Hall Amphitheater.
-1:00 - 2:50 Neurosurgery-Roentgenology Conference; W. T. Peyton, Harold O.
Petorson and Staff; Todd Amphitheater, U. H.
2:00 - 3:00 Dermatology and Syphilology Conference; Presentation of Selected
Cases of the Week; H. E. Michelson and Staff; W-312, U. H.
3:00 - 4:00 Neuropathological Conferenco; F. Tichy; Todd Amphitheater, U. H.
4:00 - 5:00 Dermatology Seminar; W-312, U. H.
5:00 - Urology Seminar; Eustis Amphitheater, U. H.
Ancker Hospital
1:00 - 3:00 Pathology-Surgery Conference; Auditorium.
Minneapolis General Hospital
8:30 -
10:00 -
1:30 -
Pediatric Rounds; Dr. Lowry; 7th Floor Annex.
Pediatric Rounds; Franklin Top; 7th Floor Annex.
Pediatric Rounds; Dr. Ulstrom; 5th Floor Annex.
Veterans Administration Hospital
10:30 - 11:20 Medicine Grand Rounds; Conference Room, Bldg. I.
1:00 -
1:30 -
Microscopic-Pathology Conference; E. T. Bell; Conference Room, Bldg. I.
Chest Conference; Wm. Tucker and J. A. Myers; Ward 62, Day Room.
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Friday, April 20 (Cont.)
Veterans Administration Hospital (Cont.)
3:00 - Renal Pathology; E. T. Bell; Conference Room, Bldg. I.
Saturday, April 21
Medical School ~nd University Hospitals
7:45 - 8:50 Orthopodic X-ray Conference; Wallace H. Cole and Staff; M-109, U. H.
9:00 - 9:50 Medicine Case Presentation; C. J. Watson and Staff; E-221, U. H.
9:00 - 10:30 Pediatric Grand Rounds; I. MCQuarrie and Staff; Eustis Amphitheater,
U. H.
9:15 - 10:00 Surgery-Roentgenology Conference; J. Friedman, O. H. Wangensteen and
Staff; Todd Amphitheater, U. H.
10:00 - 11:30 Surgery Conference; O. H. Wangensteen and Staff; Todd Amphitheater,
U. H.
10:00 - 11:50 Medicine Ward Rounds; C. J. Watson and Staff; E-221, U. H.
10:00 - 12:50 Obstetrics and Gynecology Grand Rounds; J. L. McKelvey and Staff;
Station 44, U. H.
11:00 - 12:00 Anatomy Seminar; Further Studies on the Cerebral Cortex, Berry
Campbell; Postmortem Changes in Neurones of the Cat, Sam Cornwell;
226 Institute of Anatomy.
Ancker Hospital
8:30 - 9:30 Sl~gery Conference; Auditorium.
Minneapolis General Hospital
11:00 - 12:00 Pediatric Clinic; Dr. Thomas and Dr. Good; Classroom, 7th Floor Annex.
Veterans Administration Hospital
8:00 -
8:30 -
Proctology Rounds; W. C. Bernstein and Staff; Bldg. III.
Hematology Rounds; P. Hagen and E. F. Englund.
